DCF Valuation Rank

View and export this data going back to 2017. Start your Free Trial

What is BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Valuation Rank Related Terms

Thank you for viewing the detailed overview of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o BNY Mellon Investment Adviser, Inc, 240 Greenwich Street, New York, NY, USA, 10286

Website

https://www.bny.com

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc is a diversified closed-end management investment company. Its investment objectives are to seek high current income and to return at least the Fund's original NAV to holders of record of common shares on or about the termination date. It has a dynamic, multi-asset portfolio designed to access multiple sub-investment grade credit opportunities for enhanced yield potential with active risk management.

Executives

Bushra Mannan	other: Director of BNYMIA (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Irene Papadoulis	other: Director of BNYMIA (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Ping Jiang	other: Dir. of Invest. Oversight (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Bradley J Skapyak	officer: President	200 PARK AVENUE, NEW YORK NY 10166
Joseph Martella	officer: VP	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10288
Daniel Goldstein	officer: VP	240 GREENWICH STREET, NEW YORK NY 10286
Robert J. Pomeroy	officer: VP; Investment Adviser	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Vinay Patel	other: Head of Finance of Sub-Adviser	200 PARK AVE, NEW YORK CITY NY 10166
Alcentra Ny, Llc	other: Sub-Adviser	200 PARK AVENUE, 7TH FLOOR, NEW YORK NY 10166
Brandon Chao	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Laurence Raven	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Ross Curran	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Cathy Bevan	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Daire Wheeler	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Eric Larsson	other: Portfolio Mgr of Sub-Adviser	C/O ALCENTRA NY LLC, 200 PARK AVENUE, NEW YORK CITY NY 10166